Global Influenza Vaccine Market By Type (Live Attenuated, Inactivated), By Valency (Quadrivalent, Trivalent), By Age Group (Pediatrics, Adults), By Route of Administration (Injection, Nasal Spray), By Distribution Channel (Hospital Pharmacy & Retail Pharmacy, Government Suppliers, Other Distribution Channels), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: July 2024
- Report ID: 57384
- Number of Pages: 272
- Format:
- keyboard_arrow_up
- 1. Executive Summary
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 1.4. Key Analysis
- 1.5. Key Findings by Major Segments
- 1.6. Top strategies by Major Players
- 2. Global Influenza Vaccine Market Overview
- 2.1. Influenza Vaccine Market Dynamics
- 2.1.1. Drivers
- 2.1.2. Opportunities
- 2.1.3. Restraints
- 2.1.4. Challenges
- 2.2. Macro-economic Factors
- 2.3. Regulatory Framework
- 2.4. Market Investment Feasibility Index
- 2.5. PEST Analysis
- 2.6. PORTER’S Five Force Analysis
- 2.7. Drivers & Restraints Impact Analysis
- 2.8. Industry Chain Analysis
- 2.9. Cost Structure Analysis
- 2.10. Marketing Strategy
- 2.11. Russia-Ukraine War Impact Analysis
- 2.12. Opportunity Map Analysis
- 2.13. Market Competition Scenario Analysis
- 2.14. Product Life Cycle Analysis
- 2.15. Opportunity Orbits
- 2.16. Manufacturer Intensity Map
- 2.17. Major Companies sales by Value & Volume
- 2.1. Influenza Vaccine Market Dynamics
- 3. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
- 3.1. Global Influenza Vaccine Market Analysis, 2016-2021
- 3.2. Global Influenza Vaccine Market Opportunity and Forecast, 2023-2032
- 3.3. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
- 3.3.1. Global Influenza Vaccine Market Analysis by Type: Introduction
- 3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 3.3.3. Live Attenuated
- 3.3.4. Inactivated
- 3.4. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
- 3.4.1. Global Influenza Vaccine Market Analysis by Valency: Introduction
- 3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
- 3.4.3. Quadrivalent
- 3.4.4. Trivalent
- 3.5. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
- 3.5.1. Global Influenza Vaccine Market Analysis by Age Group: Introduction
- 3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
- 3.5.3. Pediatrics
- 3.5.4. Adults
- 3.6. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
- 3.6.1. Global Influenza Vaccine Market Analysis by Route of Administration: Introduction
- 3.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
- 3.6.3. Injection
- 3.6.4. Nasal Spray
- 3.7. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
- 3.7.1. Global Influenza Vaccine Market Analysis by Distribution Channel: Introduction
- 3.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
- 3.7.3. Hospital Pharmacy & Retail Pharmacy
- 3.7.4. Government Suppliers
- 3.7.5. Other Distribution Channels
- 4. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
- 4.1. North America Influenza Vaccine Market Analysis, 2016-2021
- 4.2. North America Influenza Vaccine Market Opportunity and Forecast, 2023-2032
- 4.3. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
- 4.3.1. North America Influenza Vaccine Market Analysis by Type: Introduction
- 4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 4.3.3. Live Attenuated
- 4.3.4. Inactivated
- 4.4. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
- 4.4.1. North America Influenza Vaccine Market Analysis by Valency: Introduction
- 4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
- 4.4.3. Quadrivalent
- 4.4.4. Trivalent
- 4.5. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
- 4.5.1. North America Influenza Vaccine Market Analysis by Age Group: Introduction
- 4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
- 4.5.3. Pediatrics
- 4.5.4. Adults
- 4.6. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
- 4.6.1. North America Influenza Vaccine Market Analysis by Route of Administration: Introduction
- 4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
- 4.6.3. Injection
- 4.6.4. Nasal Spray
- 4.7. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
- 4.7.1. North America Influenza Vaccine Market Analysis by Distribution Channel: Introduction
- 4.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
- 4.7.3. Hospital Pharmacy & Retail Pharmacy
- 4.7.4. Government Suppliers
- 4.7.5. Other Distribution Channels
- 4.8. North America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 4.8.1. North America Influenza Vaccine Market Analysis by Country : Introduction
- 4.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 4.8.2.1. The US
- 4.8.2.2. Canada
- 4.8.2.3. Mexico
- 5. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
- 5.1. Western Europe Influenza Vaccine Market Analysis, 2016-2021
- 5.2. Western Europe Influenza Vaccine Market Opportunity and Forecast, 2023-2032
- 5.3. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
- 5.3.1. Western Europe Influenza Vaccine Market Analysis by Type: Introduction
- 5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 5.3.3. Live Attenuated
- 5.3.4. Inactivated
- 5.4. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
- 5.4.1. Western Europe Influenza Vaccine Market Analysis by Valency: Introduction
- 5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
- 5.4.3. Quadrivalent
- 5.4.4. Trivalent
- 5.5. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
- 5.5.1. Western Europe Influenza Vaccine Market Analysis by Age Group: Introduction
- 5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
- 5.5.3. Pediatrics
- 5.5.4. Adults
- 5.6. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
- 5.6.1. Western Europe Influenza Vaccine Market Analysis by Route of Administration: Introduction
- 5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
- 5.6.3. Injection
- 5.6.4. Nasal Spray
- 5.7. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
- 5.7.1. Western Europe Influenza Vaccine Market Analysis by Distribution Channel: Introduction
- 5.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
- 5.7.3. Hospital Pharmacy & Retail Pharmacy
- 5.7.4. Government Suppliers
- 5.7.5. Other Distribution Channels
- 5.8. Western Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 5.8.1. Western Europe Influenza Vaccine Market Analysis by Country : Introduction
- 5.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 5.8.2.1. Germany
- 5.8.2.2. France
- 5.8.2.3. The UK
- 5.8.2.4. Spain
- 5.8.2.5. Italy
- 5.8.2.6. Portugal
- 5.8.2.7. Ireland
- 5.8.2.8. Austria
- 5.8.2.9. Switzerland
- 5.8.2.10. Benelux
- 5.8.2.11. Nordic
- 5.8.2.12. Rest of Western Europe
- 6. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
- 6.1. Eastern Europe Influenza Vaccine Market Analysis, 2016-2021
- 6.2. Eastern Europe Influenza Vaccine Market Opportunity and Forecast, 2023-2032
- 6.3. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
- 6.3.1. Eastern Europe Influenza Vaccine Market Analysis by Type: Introduction
- 6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 6.3.3. Live Attenuated
- 6.3.4. Inactivated
- 6.4. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
- 6.4.1. Eastern Europe Influenza Vaccine Market Analysis by Valency: Introduction
- 6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
- 6.4.3. Quadrivalent
- 6.4.4. Trivalent
- 6.5. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
- 6.5.1. Eastern Europe Influenza Vaccine Market Analysis by Age Group: Introduction
- 6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
- 6.5.3. Pediatrics
- 6.5.4. Adults
- 6.6. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
- 6.6.1. Eastern Europe Influenza Vaccine Market Analysis by Route of Administration: Introduction
- 6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
- 6.6.3. Injection
- 6.6.4. Nasal Spray
- 6.7. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
- 6.7.1. Eastern Europe Influenza Vaccine Market Analysis by Distribution Channel: Introduction
- 6.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
- 6.7.3. Hospital Pharmacy & Retail Pharmacy
- 6.7.4. Government Suppliers
- 6.7.5. Other Distribution Channels
- 6.8. Eastern Europe Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 6.8.1. Eastern Europe Influenza Vaccine Market Analysis by Country : Introduction
- 6.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 6.8.2.1. Russia
- 6.8.2.2. Poland
- 6.8.2.3. The Czech Republic
- 6.8.2.4. Greece
- 6.8.2.5. Rest of Eastern Europe
- 7. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
- 7.1. APAC Influenza Vaccine Market Analysis, 2016-2021
- 7.2. APAC Influenza Vaccine Market Opportunity and Forecast, 2023-2032
- 7.3. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
- 7.3.1. APAC Influenza Vaccine Market Analysis by Type: Introduction
- 7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 7.3.3. Live Attenuated
- 7.3.4. Inactivated
- 7.4. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
- 7.4.1. APAC Influenza Vaccine Market Analysis by Valency: Introduction
- 7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
- 7.4.3. Quadrivalent
- 7.4.4. Trivalent
- 7.5. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
- 7.5.1. APAC Influenza Vaccine Market Analysis by Age Group: Introduction
- 7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
- 7.5.3. Pediatrics
- 7.5.4. Adults
- 7.6. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
- 7.6.1. APAC Influenza Vaccine Market Analysis by Route of Administration: Introduction
- 7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
- 7.6.3. Injection
- 7.6.4. Nasal Spray
- 7.7. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
- 7.7.1. APAC Influenza Vaccine Market Analysis by Distribution Channel: Introduction
- 7.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
- 7.7.3. Hospital Pharmacy & Retail Pharmacy
- 7.7.4. Government Suppliers
- 7.7.5. Other Distribution Channels
- 7.8. APAC Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 7.8.1. APAC Influenza Vaccine Market Analysis by Country : Introduction
- 7.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 7.8.2.1. China
- 7.8.2.2. Japan
- 7.8.2.3. South Korea
- 7.8.2.4. India
- 7.8.2.5. Australia & New Zeland
- 7.8.2.6. Indonesia
- 7.8.2.7. Malaysia
- 7.8.2.8. Philippines
- 7.8.2.9. Singapore
- 7.8.2.10. Thailand
- 7.8.2.11. Vietnam
- 7.8.2.12. Rest of APAC
- 8. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
- 8.1. Latin America Influenza Vaccine Market Analysis, 2016-2021
- 8.2. Latin America Influenza Vaccine Market Opportunity and Forecast, 2023-2032
- 8.3. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
- 8.3.1. Latin America Influenza Vaccine Market Analysis by Type: Introduction
- 8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 8.3.3. Live Attenuated
- 8.3.4. Inactivated
- 8.4. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
- 8.4.1. Latin America Influenza Vaccine Market Analysis by Valency: Introduction
- 8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
- 8.4.3. Quadrivalent
- 8.4.4. Trivalent
- 8.5. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
- 8.5.1. Latin America Influenza Vaccine Market Analysis by Age Group: Introduction
- 8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
- 8.5.3. Pediatrics
- 8.5.4. Adults
- 8.6. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
- 8.6.1. Latin America Influenza Vaccine Market Analysis by Route of Administration: Introduction
- 8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
- 8.6.3. Injection
- 8.6.4. Nasal Spray
- 8.7. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
- 8.7.1. Latin America Influenza Vaccine Market Analysis by Distribution Channel: Introduction
- 8.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
- 8.7.3. Hospital Pharmacy & Retail Pharmacy
- 8.7.4. Government Suppliers
- 8.7.5. Other Distribution Channels
- 8.8. Latin America Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 8.8.1. Latin America Influenza Vaccine Market Analysis by Country : Introduction
- 8.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 8.8.2.1. Brazil
- 8.8.2.2. Colombia
- 8.8.2.3. Chile
- 8.8.2.4. Argentina
- 8.8.2.5. Costa Rica
- 8.8.2.6. Rest of Latin America
- 9. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, 2016-2032
- 9.1. Middle East & Africa Influenza Vaccine Market Analysis, 2016-2021
- 9.2. Middle East & Africa Influenza Vaccine Market Opportunity and Forecast, 2023-2032
- 9.3. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Type, 2016-2032
- 9.3.1. Middle East & Africa Influenza Vaccine Market Analysis by Type: Introduction
- 9.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Type, 2016-2032
- 9.3.3. Live Attenuated
- 9.3.4. Inactivated
- 9.4. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Valency, 2016-2032
- 9.4.1. Middle East & Africa Influenza Vaccine Market Analysis by Valency: Introduction
- 9.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Valency, 2016-2032
- 9.4.3. Quadrivalent
- 9.4.4. Trivalent
- 9.5. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Age Group, 2016-2032
- 9.5.1. Middle East & Africa Influenza Vaccine Market Analysis by Age Group: Introduction
- 9.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Age Group, 2016-2032
- 9.5.3. Pediatrics
- 9.5.4. Adults
- 9.6. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Route of Administration, 2016-2032
- 9.6.1. Middle East & Africa Influenza Vaccine Market Analysis by Route of Administration: Introduction
- 9.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Route of Administration, 2016-2032
- 9.6.3. Injection
- 9.6.4. Nasal Spray
- 9.7. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Distribution Channel, 2016-2032
- 9.7.1. Middle East & Africa Influenza Vaccine Market Analysis by Distribution Channel: Introduction
- 9.7.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Distribution Channel, 2016-2032
- 9.7.3. Hospital Pharmacy & Retail Pharmacy
- 9.7.4. Government Suppliers
- 9.7.5. Other Distribution Channels
- 9.8. Middle East & Africa Influenza Vaccine Market Analysis, Opportunity and Forecast, By Country , 2016-2032
- 9.8.1. Middle East & Africa Influenza Vaccine Market Analysis by Country : Introduction
- 9.8.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
- 9.8.2.1. Algeria
- 9.8.2.2. Egypt
- 9.8.2.3. Israel
- 9.8.2.4. Kuwait
- 9.8.2.5. Nigeria
- 9.8.2.6. Saudi Arabia
- 9.8.2.7. South Africa
- 9.8.2.8. Turkey
- 9.8.2.9. The UAE
- 9.8.2.10. Rest of MEA
- 10. Global Influenza Vaccine Market Analysis, Opportunity and Forecast, By Region , 2016-2032
- 10.1. Global Influenza Vaccine Market Analysis by Region : Introduction
- 10.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
- 10.2.1. North America
- 10.2.2. Western Europe
- 10.2.3. Eastern Europe
- 10.2.4. APAC
- 10.2.5. Latin America
- 10.2.6. Middle East & Africa
- 11. Global Influenza Vaccine Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 11.1. Market Share Analysis
- 11.2. Company Profiles
- 11.3. Sanofi S.A.
- 11.3.1. Company Overview
- 11.3.2. Financial Highlights
- 11.3.3. Product Portfolio
- 11.3.4. SWOT Analysis
- 11.3.5. Key Strategies and Developments
- 11.4. AstraZeneca plc
- 11.4.1. Company Overview
- 11.4.2. Financial Highlights
- 11.4.3. Product Portfolio
- 11.4.4. SWOT Analysis
- 11.4.5. Key Strategies and Developments
- 11.5. CSL Limited
- 11.5.1. Company Overview
- 11.5.2. Financial Highlights
- 11.5.3. Product Portfolio
- 11.5.4. SWOT Analysis
- 11.5.5. Key Strategies and Developments
- 11.6. BIKEN Co, Ltd.
- 11.6.1. Company Overview
- 11.6.2. Financial Highlights
- 11.6.3. Product Portfolio
- 11.6.4. SWOT Analysis
- 11.6.5. Key Strategies and Developments
- 11.7. GlaxoSmithKline plc
- 11.7.1. Company Overview
- 11.7.2. Financial Highlights
- 11.7.3. Product Portfolio
- 11.7.4. SWOT Analysis
- 11.7.5. Key Strategies and Developments
- 11.8. Adeor Medical AG
- 11.8.1. Company Overview
- 11.8.2. Financial Highlights
- 11.8.3. Product Portfolio
- 11.8.4. SWOT Analysis
- 11.8.5. Key Strategies and Developments
- 11.9. Sinovac Biotech Ltd.
- 11.9.1. Company Overview
- 11.9.2. Financial Highlights
- 11.9.3. Product Portfolio
- 11.9.4. SWOT Analysis
- 11.9.5. Key Strategies and Developments
- 11.10. Viatris Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Highlights
- 11.10.3. Product Portfolio
- 11.10.4. SWOT Analysis
- 11.10.5. Key Strategies and Developments
- 11.11. Merck & Co, Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Highlights
- 11.11.3. Product Portfolio
- 11.11.4. SWOT Analysis
- 11.11.5. Key Strategies and Developments
- 11.12. EMERGEX VACCINES
- 11.12.1. Company Overview
- 11.12.2. Financial Highlights
- 11.12.3. Product Portfolio
- 11.12.4. SWOT Analysis
- 11.12.5. Key Strategies and Developments
- 11.13. Other Key Players
- 11.13.1. Company Overview
- 11.13.2. Financial Highlights
- 11.13.3. Product Portfolio
- 11.13.4. SWOT Analysis
- 11.13.5. Key Strategies and Developments
- 12. Assumptions and Acronyms
- 13. Research Methodology
- 14. Contact
- List of Figures
- Figure 1: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Type in 2022
- Figure 2: Global Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
- Figure 3: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
- Figure 4: Global Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
- Figure 5: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
- Figure 6: Global Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
- Figure 7: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
- Figure 8: Global Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
- Figure 9: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
- Figure 10: Global Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
- Figure 11: Global Influenza Vaccine Market Revenue (US$ Mn) Market Share by Region in 2022
- Figure 12: Global Influenza Vaccine Market Attractiveness Analysis by Region, 2016-2032
- Figure 13: Global Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Figure 14: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Figure 15: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 16: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Figure 17: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Figure 18: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Figure 19: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Figure 20: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Figure 21: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 22: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Figure 23: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Figure 24: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Figure 25: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Figure 26: Global Influenza Vaccine Market Share Comparison by Region (2016-2032)
- Figure 27: Global Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Figure 28: Global Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Figure 29: Global Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Figure 30: Global Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Figure 31: Global Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Figure 32: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
- Figure 33: North America Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
- Figure 34: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
- Figure 35: North America Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
- Figure 36: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
- Figure 37: North America Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
- Figure 38: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
- Figure 39: North America Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
- Figure 40: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
- Figure 41: North America Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
- Figure 42: North America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 43: North America Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
- Figure 44: North America Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Figure 45: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 46: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 47: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Figure 48: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Figure 49: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Figure 50: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Figure 51: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 52: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 53: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Figure 54: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Figure 55: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Figure 56: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Figure 57: North America Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Figure 58: North America Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Figure 59: North America Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Figure 60: North America Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Figure 61: North America Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Figure 62: North America Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Figure 63: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
- Figure 64: Western Europe Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
- Figure 65: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
- Figure 66: Western Europe Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
- Figure 67: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
- Figure 68: Western Europe Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
- Figure 69: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
- Figure 70: Western Europe Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
- Figure 71: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
- Figure 72: Western Europe Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
- Figure 73: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 74: Western Europe Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
- Figure 75: Western Europe Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Figure 76: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 77: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 78: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Figure 79: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Figure 80: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Figure 81: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Figure 82: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 83: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 84: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Figure 85: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Figure 86: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Figure 87: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Figure 88: Western Europe Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Figure 89: Western Europe Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Figure 90: Western Europe Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Figure 91: Western Europe Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Figure 92: Western Europe Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Figure 93: Western Europe Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Figure 94: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
- Figure 95: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
- Figure 96: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
- Figure 97: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
- Figure 98: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
- Figure 99: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
- Figure 100: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
- Figure 101: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
- Figure 102: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
- Figure 103: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
- Figure 104: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 105: Eastern Europe Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
- Figure 106: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Figure 107: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 108: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 109: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Figure 110: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Figure 111: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Figure 112: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Figure 113: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 114: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 115: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Figure 116: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Figure 117: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Figure 118: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Figure 119: Eastern Europe Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Figure 120: Eastern Europe Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Figure 121: Eastern Europe Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Figure 122: Eastern Europe Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Figure 123: Eastern Europe Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Figure 124: Eastern Europe Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Figure 125: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
- Figure 126: APAC Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
- Figure 127: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
- Figure 128: APAC Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
- Figure 129: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
- Figure 130: APAC Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
- Figure 131: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
- Figure 132: APAC Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
- Figure 133: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
- Figure 134: APAC Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
- Figure 135: APAC Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 136: APAC Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
- Figure 137: APAC Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Figure 138: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 139: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 140: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Figure 141: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Figure 142: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Figure 143: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Figure 144: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 145: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 146: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Figure 147: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Figure 148: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Figure 149: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Figure 150: APAC Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Figure 151: APAC Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Figure 152: APAC Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Figure 153: APAC Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Figure 154: APAC Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Figure 155: APAC Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Figure 156: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
- Figure 157: Latin America Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
- Figure 158: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
- Figure 159: Latin America Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
- Figure 160: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
- Figure 161: Latin America Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
- Figure 162: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
- Figure 163: Latin America Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
- Figure 164: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
- Figure 165: Latin America Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
- Figure 166: Latin America Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 167: Latin America Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
- Figure 168: Latin America Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Figure 169: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 170: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 171: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Figure 172: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Figure 173: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Figure 174: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Figure 175: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 176: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 177: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Figure 178: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Figure 179: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Figure 180: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Figure 181: Latin America Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Figure 182: Latin America Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Figure 183: Latin America Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Figure 184: Latin America Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Figure 185: Latin America Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Figure 186: Latin America Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Figure 187: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Typein 2022
- Figure 188: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Type, 2016-2032
- Figure 189: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Valencyin 2022
- Figure 190: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Valency, 2016-2032
- Figure 191: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Age Groupin 2022
- Figure 192: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Age Group, 2016-2032
- Figure 193: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Route of Administrationin 2022
- Figure 194: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Route of Administration, 2016-2032
- Figure 195: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Distribution Channelin 2022
- Figure 196: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Distribution Channel, 2016-2032
- Figure 197: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Market Share by Country in 2022
- Figure 198: Middle East & Africa Influenza Vaccine Market Attractiveness Analysis by Country, 2016-2032
- Figure 199: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Figure 200: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Figure 201: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Figure 202: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Figure 203: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Figure 204: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Figure 205: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Figure 206: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Figure 207: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Figure 208: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Figure 209: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Figure 210: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Figure 211: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Figure 212: Middle East & Africa Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Figure 213: Middle East & Africa Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Figure 214: Middle East & Africa Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Figure 215: Middle East & Africa Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Figure 216: Middle East & Africa Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Figure 217: Middle East & Africa Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- List of Tables
- Table 1: Global Influenza Vaccine Market Comparison by Type (2016-2032)
- Table 2: Global Influenza Vaccine Market Comparison by Valency (2016-2032)
- Table 3: Global Influenza Vaccine Market Comparison by Age Group (2016-2032)
- Table 4: Global Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
- Table 5: Global Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
- Table 6: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 7: Global Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Table 8: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Region (2016-2032)
- Table 9: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 10: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Table 11: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Table 12: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Table 13: Global Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Table 14: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
- Table 15: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 16: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Table 17: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Table 18: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Table 19: Global Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Table 20: Global Influenza Vaccine Market Share Comparison by Region (2016-2032)
- Table 21: Global Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Table 22: Global Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Table 23: Global Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Table 24: Global Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Table 25: Global Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Table 26: North America Influenza Vaccine Market Comparison by Valency (2016-2032)
- Table 27: North America Influenza Vaccine Market Comparison by Age Group (2016-2032)
- Table 28: North America Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
- Table 29: North America Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
- Table 30: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 31: North America Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Table 32: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 33: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 34: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Table 35: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Table 36: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Table 37: North America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Table 38: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 39: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 40: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Table 41: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Table 42: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Table 43: North America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Table 44: North America Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Table 45: North America Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Table 46: North America Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Table 47: North America Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Table 48: North America Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Table 49: North America Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Table 50: Western Europe Influenza Vaccine Market Comparison by Type (2016-2032)
- Table 51: Western Europe Influenza Vaccine Market Comparison by Valency (2016-2032)
- Table 52: Western Europe Influenza Vaccine Market Comparison by Age Group (2016-2032)
- Table 53: Western Europe Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
- Table 54: Western Europe Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
- Table 55: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 56: Western Europe Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Table 57: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 58: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 59: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Table 60: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Table 61: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Table 62: Western Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Table 63: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 64: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 65: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Table 66: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Table 67: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Table 68: Western Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Table 69: Western Europe Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Table 70: Western Europe Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Table 71: Western Europe Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Table 72: Western Europe Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Table 73: Western Europe Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Table 74: Western Europe Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Table 75: Eastern Europe Influenza Vaccine Market Comparison by Type (2016-2032)
- Table 76: Eastern Europe Influenza Vaccine Market Comparison by Valency (2016-2032)
- Table 77: Eastern Europe Influenza Vaccine Market Comparison by Age Group (2016-2032)
- Table 78: Eastern Europe Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
- Table 79: Eastern Europe Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
- Table 80: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 81: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Table 82: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 83: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 84: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Table 85: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Table 86: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Table 87: Eastern Europe Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Table 88: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 89: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 90: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Table 91: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Table 92: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Table 93: Eastern Europe Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Table 94: Eastern Europe Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Table 95: Eastern Europe Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Table 96: Eastern Europe Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Table 97: Eastern Europe Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Table 98: Eastern Europe Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Table 99: Eastern Europe Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Table 100: APAC Influenza Vaccine Market Comparison by Type (2016-2032)
- Table 101: APAC Influenza Vaccine Market Comparison by Valency (2016-2032)
- Table 102: APAC Influenza Vaccine Market Comparison by Age Group (2016-2032)
- Table 103: APAC Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
- Table 104: APAC Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
- Table 105: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 106: APAC Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Table 107: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 108: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 109: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Table 110: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Table 111: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Table 112: APAC Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Table 113: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 114: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 115: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Table 116: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Table 117: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Table 118: APAC Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Table 119: APAC Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Table 120: APAC Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Table 121: APAC Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Table 122: APAC Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Table 123: APAC Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Table 124: APAC Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Table 125: Latin America Influenza Vaccine Market Comparison by Type (2016-2032)
- Table 126: Latin America Influenza Vaccine Market Comparison by Valency (2016-2032)
- Table 127: Latin America Influenza Vaccine Market Comparison by Age Group (2016-2032)
- Table 128: Latin America Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
- Table 129: Latin America Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
- Table 130: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 131: Latin America Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Table 132: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 133: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 134: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Table 135: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Table 136: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Table 137: Latin America Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Table 138: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 139: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 140: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Table 141: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Table 142: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Table 143: Latin America Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Table 144: Latin America Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Table 145: Latin America Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Table 146: Latin America Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Table 147: Latin America Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Table 148: Latin America Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Table 149: Latin America Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- Table 150: Middle East & Africa Influenza Vaccine Market Comparison by Type (2016-2032)
- Table 151: Middle East & Africa Influenza Vaccine Market Comparison by Valency (2016-2032)
- Table 152: Middle East & Africa Influenza Vaccine Market Comparison by Age Group (2016-2032)
- Table 153: Middle East & Africa Influenza Vaccine Market Comparison by Route of Administration (2016-2032)
- Table 154: Middle East & Africa Influenza Vaccine Market Comparison by Distribution Channel (2016-2032)
- Table 155: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 156: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) (2016-2032)
- Table 157: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Country (2016-2032)
- Table 158: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Type (2016-2032)
- Table 159: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Valency (2016-2032)
- Table 160: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Age Group (2016-2032)
- Table 161: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Route of Administration (2016-2032)
- Table 162: Middle East & Africa Influenza Vaccine Market Revenue (US$ Mn) Comparison by Distribution Channel (2016-2032)
- Table 163: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
- Table 164: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Type (2016-2032)
- Table 165: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Valency (2016-2032)
- Table 166: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Age Group (2016-2032)
- Table 167: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Route of Administration (2016-2032)
- Table 168: Middle East & Africa Influenza Vaccine Market Y-o-Y Growth Rate Comparison by Distribution Channel (2016-2032)
- Table 169: Middle East & Africa Influenza Vaccine Market Share Comparison by Country (2016-2032)
- Table 170: Middle East & Africa Influenza Vaccine Market Share Comparison by Type (2016-2032)
- Table 171: Middle East & Africa Influenza Vaccine Market Share Comparison by Valency (2016-2032)
- Table 172: Middle East & Africa Influenza Vaccine Market Share Comparison by Age Group (2016-2032)
- Table 173: Middle East & Africa Influenza Vaccine Market Share Comparison by Route of Administration (2016-2032)
- Table 174: Middle East & Africa Influenza Vaccine Market Share Comparison by Distribution Channel (2016-2032)
- 1. Executive Summary
- Sanofi S.A.
- AstraZeneca Plc Company Profile
- CSL Limited
- BIKEN Co, Ltd.
- GlaxoSmithKline plc
- Abbott Laboratories
- Sinovac Biotech Ltd.
- Viatris Inc.
- Merck & Co, Inc.
- EMERGEX VACCINES
- Pfizer Inc Company Profile
- Novartis AG Company Profile
- Merck & Co., Inc.
- Johnson & Johnson
- Novavax, Inc.
- Hoffmann –La Roche Ltd
- Baxter International Inc.
- Flugen Inc.
- Vaxart Inc.
- Altimmune Inc.
- Shijiazhuang Yiling Pharmaceutical Co, Ltd
- BiondVax Pharmaceuticals Ltd.
- Daiichi Sankyo Company
- Other Key Players
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |